EXAGEN INC.
Company Information
Industry
Services-Medical Laboratories
SIC Code
8071
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting company
State of Incorporation
DE
Business Address
1261 LIBERTY WAY, VISTA, CA, 92081
Mailing Address
1261 LIBERTY WAY, VISTA, CA, 92081
Phone
(760) 560-1501
Fiscal Year End
1231
EIN
000000000
Financial Overview
FY2025
$58.02M
Total Assets
$32.22M
Cash & Equivalents
$-0.83
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 4 Insider stock transaction report | March 16, 2026 | View on SEC |
| 3 Initial insider ownership report | March 16, 2026 | View on SEC |
| 4 Insider stock transaction report | March 16, 2026 | View on SEC |
| 8-K Current report of material events | March 10, 2026 | View on SEC |
| 10-K Annual financial report | March 10, 2026 | View on SEC |
| 4 Insider stock transaction report | March 4, 2026 | View on SEC |
| 4 Insider stock transaction report | February 25, 2026 | View on SEC |
| 4 Insider stock transaction report | February 25, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 17, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 11, 2026 | View on SEC |
Annual Reports
10-K
March 10, 2026
- Flagship AVISE CTD Test for autoimmune diseases drives commercialization efforts and market penetration.
- Successfully raised significant capital through a public offering, At-The-Market (ATM) sales agreement, and new loan facilities.
Insider Trading
SELL
2 insiders
3 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 8071)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.